Pharmaceutical Market Dynamics 2021-2031
MARKTÜBERSICHT
Pharmazeutika ist ein breites Segment, das eine Gruppe von Chemikalien zusammenfasst, die nach ihrer pharmakologischen Wirkung und therapeutischen Verwendung klassifiziert werden. Alkaloide waren beispielsweise die ersten rein pflanzlichen Arzneimittel; Dazu gehören Chinin, Nikotin, Kokain, Atropin und Morphin. Ebenso sind einige Arzneimittel tierischen Ursprungs, darunter hormonhaltige Drüsenextrakte. Arzneimittel oder Arzneimittel tierischen Ursprungs sind biologische Arzneimittel, Biosimilars und Impfstoffe. Diese pharmazeutischen Produkte diagnostizieren, behandeln und verhindern chronische Krankheiten wie Krebs, Diabetes und genetische Störungen.
MARKTSEGMENTIERUNG
- Je nach Produkt ist der Markt in Markenmedikamente, Generika, biologische Arzneimittel und Biosimilars unterteilt Produkte, Impfstoffe und andere.
MARKTTYNAMIK
Treiber-
- < span style="Schriftfamilie: Verdana, Genf, Sans-Serif; Schriftgröße: 10pt;">Wachsende Prävalenz chronischer und akuter Krankheiten
- Steigende Forschung und Entwicklungen in der Pharmaindustrie
- Steigerung der Produktion pharmazeutischer Produkte
Restraint-
- Strenge Vorschriften der Aufsichtsbehörden und zunehmende Produktrückrufe
REGIONAL FRAMEWORK
Der Bericht bietet einen umfassenden Überblick über die Branche, einschließlich qualitativer und quantitativer Daten. Er bietet einen globalen Marktüberblick und eine Prognose auf der Grundlage verschiedener Segmente. Außerdem bietet er Marktgrößen- und Prognoseschätzungen für Länder Statistiken von 2022 bis 2031. Der Pharmamarkt jeder Region ist weiter nach jeweiligen Ländern und Segmenten unterteilt.
Der Bericht analysiert Marktfaktoren, die sowohl die Nachfrage- als auch die Angebotsseite beeinflussen, sowie die Marktdynamik, die den Markt während des Prognosezeitraums beeinflusst, wie z. B. Treiber, Beschränkungen, Chancen und zukünftige Trends. Der Bericht enthält auch eine umfassende PEST-Analyse für Brasilien nach Bewertung der politischen, wirtschaftlichen, sozialen und technologischen Faktoren, die den Pharmamarkt in diesen Regionen beeinflussen.
Auswirkungen von COVID-19 auf den Pharmamarkt
Die anhaltende COVID-19-Pandemie hat einen hohen Tribut an das menschliche Leben, die Gesundheitsversorgung, die Weltwirtschaft und fast jeden Aspekt des menschlichen Lebens gefordert. Die COVID-19-Pandemie hat sich auf alle Phasen der Arzneimittelentwicklung ausgewirkt zwang viele Arzneimittelentwicklungsunternehmen und klinische Forschungsorganisationen, zumindest einige ihrer klinischen Studien auf Eis zu legen. Trotz dieser verheerenden Auswirkungen hat COVID-19 auch viele Elemente der Arzneimittelforschung und -entwicklung mobilisiert und vereint, um nach Therapien zu suchen, um dieses dringendste Problem der öffentlichen Gesundheit anzugehen Notfall. Die COVID-19-Pandemie hat auch Auswirkungen auf die Versorgung mit Wirkstoffen und Inhaltsstoffen sowie den Import und Export von Arzneimitteln.
MARKTSPIELER
Der Bericht behandelt wichtige Entwicklungen auf dem Pharmamarkt mit Schwerpunkt auf zwei Hauptstrategien wie organischen und anorganischen Wachstumsstrategien. Verschiedene Unternehmen konzentrieren sich auf organische Wachstumsstrategien, zu denen die Einführung neuer Produkte und Produktzulassungen durch autorisierte Unternehmen gehören Gremien und andere wie Patente und Veranstaltungen. Aktivitäten zu anorganischen Wachstumsstrategien umfassen normalerweise strategische Akquisitionen sowie Partnerschaften und Kooperationen zwischen den Unternehmen. Diese Aktivitäten haben den Weg für die Ausweitung des Geschäfts und des Kundenstamms der Marktteilnehmer geebnet. Die Marktzahler aus dem Pharmamarkt dürften angesichts der steigenden Nachfrage nach Pharmazeutika auf dem Weltmarkt lukrative Wachstumschancen haben.
Der Bericht enthält auch die Profile wichtiger Unternehmen sowie deren SWOT-Analyse und Marktstrategien im Pharmamarkt. Außerdem konzentriert sich der Bericht auf führende Branchenakteure mit Informationen wie Unternehmensprofilen, Komponenten und Dienstleistungen angeboten, Finanzinformationen der letzten 3 Jahre und die wichtigsten Entwicklungen in den letzten fünf Jahren.
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Celgene Corporation
- Shire plc
- Zoetis Inc.
Das engagierte Forschungs- und Analyseteam des Insight Partners besteht aus erfahrenen Fachleuten mit fortgeschrittener statistischer Expertise und bietet verschiedene Anpassungsmöglichkeiten in der bestehenden Studie.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Celgene Corporation
- Shire plc
- Zoetis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For